IP Verse

Improved Process For Production Of Fibrinogen And Fibrinogen Produced Thereby - EP2825555

The patent EP2825555 was granted to Octapharma on Jul 12, 2017. The application was originally filed on Mar 12, 2013 under application number EP13709190A. The patent is currently recorded with a legal status of "Revoked".

EP2825555

OCTAPHARMA
Application Number
EP13709190A
Filing Date
Mar 12, 2013
Status
Revoked
Dec 6, 2023
Grant Date
Jul 12, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTESTApr 12, 2018TER MEER STEINMEISTER & PARTNER -
STRAWMANApr 9, 2018MURGITROYD -

Patent Citations (45) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0131740
DESCRIPTIONEP0555135
DESCRIPTIONEP0771324
DESCRIPTIONEP1240200
DESCRIPTIONEP1457497
DESCRIPTIONEP1519944
DESCRIPTIONUS2006009376
DESCRIPTIONUS2008003272
DESCRIPTIONUS2008181878
DESCRIPTIONUS7919592
DESCRIPTIONWO2009155626
DESCRIPTIONWO2012038410
DESCRIPTIONWO9522316
INTERNATIONAL-SEARCH-REPORTEP0555135
INTERNATIONAL-SEARCH-REPORTUS6037457
INTERNATIONAL-SEARCH-REPORTWO2009155626
INTERNATIONAL-SEARCH-REPORTWO9602571
OPPOSITIONEP0555135
OPPOSITIONEP1250929
OPPOSITIONEP1393741
OPPOSITIONEP1457497
OPPOSITIONEP1739093
OPPOSITIONUS2006009376
OPPOSITIONUS2008207878
OPPOSITIONUS2011114524
OPPOSITIONUS4116635
OPPOSITIONUS4650678
OPPOSITIONUS4960757
OPPOSITIONUS5834420
OPPOSITIONUS6037457
OPPOSITIONUS7009039
OPPOSITIONUS7045601
OPPOSITIONUS7211650
OPPOSITIONUS7442308
OPPOSITIONUS7550567
OPPOSITIONWO0047621
OPPOSITIONWO0148016
OPPOSITIONWO2004007533
OPPOSITIONWO2009155626
OPPOSITIONWO2012038410
OPPOSITIONWO2014085861
OPPOSITIONWO9602571
OTHEREP1739093
OTHERUS2011114524
OTHERWO0148016

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Citratantikoagulation", Wikipedia, (20110204), URL: https://web.archive.org/web/20111128123450/https://de.wikipedia.org/wiki/Citratantikoagulation, XP055492233-
OPPOSITION- KAZAI L A; ET AL, "THE PREPARATION AND SOME PROPERTIES OF FIBRINOTEN PRECIPITATED FROM HUMAN PLASMA BY GLYCINE", Proceedings of the Society for Experimental Biology and Medi,, (19630801), vol. 113, pages 989 - 994, XP009002132-
OPPOSITION- LOTTSPEICH F et al., Bioanalytik, 2. Auflage, (20060000), page 19, XP055492248-
OPPOSITION- Holm B; Nilsen D W T; Kierulf P; Godal H C, "Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma", Thrombosis Research, (19850000), vol. 37, no. 1, pages 165 - 76, XP022880048
OPPOSITION- Jenny P. Glusker, "Citrate conformation and chelation: enzymic implications", Acc. Chem. Res., (19800000), vol. 13, pages 345 - 352, XP055492263
OPPOSITION- Seung-Yong Jung, Soon-Mi Lim, Fernando Albertorio, Gibum Kim, Marc C. Gurau, Richard D. Yang, et al.,, "The Vroman Effect: A Molecular Level Description of Fibrinogen Displacement", J. AM. CHEM. SOC., (20031000), vol. 125, no. 42, pages 12782 - 12786, XP055479466
OPPOSITION- OKUDA et al., "Quality control material for plasma fibrinogen test produced from purified human fibrinogen", Journal of Automated Methods & Management in Chemistry, (20030700), vol. 25, no. 4, pages 79 - 85, XP055479469
OPPOSITION- M Burnouf-Radosevich, Burnouf T, Huart J J, "Biochemical and Physical Properties of a Solvent-Detergent-Treated Fibrin Glue", VOX SANGUINIS, (19900000), vol. 58, no. 2, pages 77 - 84, XP055479478
OPPOSITION- Daniel Fernández, Boix Ester, Pallarès Irantzu, Avilés Francesc X., Vendrell Josep, "Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase A", Enzyme Research, (20110000), vol. 2011, pages 1 - 8, XP055492265

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents